Short term analysis
In total 30 patients with DED were screened. 20 patients fulfilled the inclusion criteria, had no exclusion criteria, and were randomized to receive one of the two study medications (CN-group: n = 10; 5 males; 5 females; mean age = 40.8 ± 16.9 years; F6H8-group: n = 10; 3 males; 7 females; mean age = 39.2 ± 18.5 years). 10 of the 20 patients were randomly selected whose second eye served as a control group (control: n = 10; 6 males; 4 females; mean age 41.2 ± 19.0). There were no significant differences gender (X